Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

PMPRB Seminars Offered in CanadaPMPRB Seminars Offered in Canada
VS
Teva PharmaceuticalsTeva Pharmaceuticals
PMPRB Seminars Offered in Canada

PMPRB Seminars Offered in Canada

N/A

Last Update: 11/03/2026

View Profile

Seminars designed to provide Fundamental or Advanced understanding of PMPRB policies. Process, methodologies and strategic considerations involved in price review for both new and existing drugs.

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:30
12-month incidents
0
Known data breaches
0
Attack type number
0
Teva Pharmaceuticals

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, IL, 6944020

Last Update: 11/09/2026

View Profile
Between 800 and 849
http://www.tevapharm.com
809/1000Good

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:29,951
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
PMPRB Seminars Offered in Canada

PMPRB Seminars Offered in Canada

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Teva Pharmaceuticals

Teva Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for PMPRB Seminars Offered in Canada in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Teva Pharmaceuticals in 2026.

Incidents

Incident History - PMPRB Seminars Offered in Canada (X = Date, Y = Severity)

PMPRB Seminars Offered in Canada cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
PMPRB Seminars Offered in Canada

PMPRB Seminars Offered in Canada

Incidents
No explicit notable incidents reported.
Teva Pharmaceuticals

Teva Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has experienced at least one data breach ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one holds the most compliance certifications ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has the most subsidiaries ?
Between PMPRB Seminars Offered in Canada company and Teva Pharmaceuticals company, which one has the largest number of employees ?
Between PMPRB Seminars Offered in Canada and Teva Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between PMPRB Seminars Offered in Canada and Teva Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - PMPRB Seminars Offered in Canada or Teva Pharmaceuticals ?
Which company is PCI DSS compliant - PMPRB Seminars Offered in Canada or Teva Pharmaceuticals ?
Between PMPRB Seminars Offered in Canada and Teva Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between PMPRB Seminars Offered in Canada and Teva Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-113705
SUMMARY

A vulnerability was determined in a2aproject a2a-rs up to 0.4.3. This issue affects some unknown processing of the file a2a-server/src/error.rs. Executing a manipulation can lead to information exposure through error message. The attack can be executed remotely. This patch is called 713b943af94ab2d521d483b841618b97a2e78a4d. A patch should be applied to remediate this issue.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-9825
SUMMARY

IBM Cyber Fraud 1.0.0 through 1.0.2 has a missing secure attribute allowing sensitive cookies to be transmitted over unencrypted connections, potentially enabling an attacker to intercept session data through network-based attacks.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94402
SUMMARY

IBM Carbon Charts 0.4.0 through 1.27.19 is vulnerable to cross-site scripting. The MeterChart component's Title.truncateTitle() function re-inserts a substring of user-supplied label text into the DOM via an unsanitized innerHTML write when the title exceeds the available container width. A remote attacker could exploit this vulnerability to execute arbitrary JavaScript in the victim's browser session.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
IMPACT SCORE
2.7
EXPLOITABILITY
2.8
CVE-2026-93888
SUMMARY

IBM Sterling Connect Direct for Unix 6.4.0.0 through 6.4.0.6 and 6.3.0.0 through 6.3.0.7 apnotify utility is vulnerable to a code injection due to insufficient validation of user input.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-93744
SUMMARY

IBM i 7.3, 7.4, 7.5, and 7.6 could allow an unathenticated remote attacker to bypass security restrictions due to improper access control. By sending a specially crafted HTTP request to any URL within the Navigator application prior to authentication, a bad actor could exploit this vulnerability to alter server-side session security state.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
3.9